How Lithuania aims to become a leading European biotech hub

By Ben Hargreaves

- Last updated on GMT

Pic:getty/diegograndi
Pic:getty/diegograndi

Related tags: Lithuania, Europe

Lithuania’s life sciences industry is growing at one of the fastest rates in Europe. Ahead of BIO, Innovation Agency Lithuania explains what the country’s plans are for future growth in the area and how this is built upon students heading into STEM studies.

The Baltic nation set itself a target of the life sciences being responsible for 5% of its GDP by 2030, which represented a potential five-fold increase at the time of the announcement in 2021.

Ahead of the BIO International Conference, Innovation Agency Lithuania, the country’s organization representing various business sectors, noted that the country is keen to strengthen its links to business in the US, which represented 28% of its life sciences exports in 2021. Recently, Northway Biotech, a Lithuanian contract development and manufacturing organization, consolidated this growing relationship by creating a manufacturing facility​ in Boston, US.

Rasa Uždavinytė, director of international trade development at Innovation Agency Lithuania, told BioPharma-Reporter, “Lithuania’s biotechnology sector has been steadily growing with a rate of 33% over the last several years. There are 26 research and development centers in the country including six dedicated to life sciences. Furthermore, there are seven universities and seven colleges that offer studies in the life sciences field.”

The country’s focus on the sciences has paid off in the number of students who are choosing to pursue STEM subjects, with 25% of students choosing to study such academic disciplines. In another bonus for the country, given the overall greater push for inclusion and diversity across the industry​, 58% of researchers in Lithuania are women.

In terms of what Innovation Agency Lithuania itself is tasked to do, Uždavinytė explained how it aims to be an entry point for foreign businesses to connect with partners in Lithuania and provide financial support to ‘innovative projects’ of all types of organizations.

Connecting to partners

One of the agency’s tasks at BIO is to aid Lithuanian companies to connect with partners, and the country has a contingent of eight life sciences companies attending the event, one of which is Biomapas, a contract research organization (CRO).

Biomapas specializes in working with biological product developers, providing regulatory, clinical and pharmacovigilance services. Its services can progress assets from the preclinical stage through to final Phase III trials.

When asked for more details about the company’s work, Regina Auškalnienė, chief global clinical research officer at Biomapas, said, “Our clinical research team focuses on early phase clinical trials' delivery, thus linking the drug developer, the investigation's site, and the patients. We also own a specialized early phase clinical trial site called BIO1, which is located inside a large university hospital with access to all required knowledge and technology to identify patients suitable to participate in clinical trials and ensure patients' safety.”

Auškalnienė added that the company’s location within Lithuania holds an advantage, as it is known as a ‘high recruiting area.’

Related news

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Multiple Sclerosis Analytical Report

Multiple Sclerosis Analytical Report

PatSnap | 15-Jun-2022 | Technical / White Paper

More than 2.3 million people are living with MS worldwide. Although there is no cure, new research and innovative treatments are continuously emerging....

Flexible Filling Solution for CMOs

Flexible Filling Solution for CMOs

Single Use Support GmBH | 18-May-2022 | Insight Guide

Achieving flexibility requires modularity of technologies.

CMOs and CDMOs aspire to be flexible for multiple applications. Efficient automated...

Related suppliers

Follow us

Products

View more

Webinars